Overview Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis Status: Terminated Trial end date: 2009-09-01 Target enrollment: Participant gender: Summary This study will assess the efficacy and safety of MBP8298 compared to placebo in subjects with Secondary Progressive Multiple Sclerosis (SPMS) Phase: Phase 3 Details Lead Sponsor: BioMS Technology Corp.